• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsSynBiotic SE
    Picture of SynBiotic SE logo

    SBX — SynBiotic SE Share News

    €1.050.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      €8.04m
    • Enterprise Value
      €11.17m
    • Revenue
      €14.31m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SBX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SBX Dividends
    • Brief: Synbiotic SE Acquires Majority Stake In Cannacare Health And Appoints Daniel Kruse As CEO

      21/08/2023 05:34
    • Brief: Synbiotic And Key.Force Joint Venture For Germany's Largest Cannabis Sales Team

      16/12/2021 06:36
    • Brief: SynBiotic Buys 50.1% In Daniel Kruse's Cannabis Companies

      01/12/2021 13:57
    • Brief: Dgap-Adhoc Synbiotic SE Says Majority Takeover Of Hemp Industry Pioneer Daniel Kruse's Group Of Companies As Part Of A Capital Increase In Kind

      30/11/2021 19:42
    • Brief: Synbiotic Completes Capital Increase Of EUR 7 Mln

      27/10/2021 07:10
    • Brief: Synbiotic Plans Canadian Cross-Listing

      12/10/2021 09:01
    • Brief: Synbiotic Plans Canadian Secondary Listing

      07/10/2021 14:52

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.